People who’ve had colorectal cancer and who have a mutation known as  PI3 kinase benefit from taking asprin to prevent recurrence, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson:  There were …

What is the benefit of asprin in reducing colorectal cancer recurrence? Elizabeth Tracey reports Read More »